Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1093/aje/kwae104 | DOI Listing |
Sci Rep
December 2024
The School of Nursing, Fujian Medical University, No. 1 Xuefu North Road, Fuzhou, 350122, Fujian, China.
Diabetes Mellitus combined with Mild Cognitive Impairment (DM-MCI) is a high incidence disease among the elderly. Patients with DM-MCI have considerably higher risk of dementia, whose daily self-care and life management (i.e.
View Article and Find Full Text PDFSci Rep
December 2024
Department of Architecture, Rafsanjan Branch, Islamic Azad University, Rafsanjan, Iran.
The advent of smart cities has brought about a paradigm shift in urban management and citizen engagement. By leveraging technological advancements, cities are now able to collect and analyze extensive data to optimize service delivery, allocate resources efficiently, and enhance the overall well-being of residents. However, as cities become increasingly interconnected and data-dependent, concerns related to data privacy and security, as well as citizen participation and representation, have surfaced.
View Article and Find Full Text PDFOtolaryngol Head Neck Surg
December 2024
Department of Otolaryngology-Head and Neck Surgery, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, Massachusetts, USA.
Objective: This study aims to assess the diversity and equity of pediatric acute otitis media (AOM) trials using ClinicalTrials.gov, focusing on participant demographics and representation to identify gaps in inclusivity and inform strategies for promoting diversity in future pediatric AOM studies.
Study Design: Retrospective analysis.
Eur J Haematol
December 2024
Alberta Health Services and University of Alberta, Edmonton, Canada.
Background: Although chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are the same biologic disease entity and warrant identical treatment approaches, patients with SLL have frequently been excluded from clinical trials in CLL.
Methods: This study assessed the representation of patients with SLL among Phase II or III clinical trials cited in the 2024 National Comprehensive Cancer Network (NCCN) treatment guidelines.
Results: Patients with SLL were explicitly eligible for only 21 (38%) of the 56 clinical trials for CLL, comprising 222 (6%) of the 3440 enrolled patients.
Arthritis Care Res (Hoboken)
December 2024
The University of British Columbia, Vancouver, British Columbia, Canada.
Objective: Despite knowledge that health outcomes vary according to patient characteristics, identity, and geography, including underrepresented populations in arthritis research remains a challenge. We conducted interviews to explore how researchers in arthritis have used equity, diversity, and inclusion (EDI) principles to inform their research.
Methods: Semi-structured interviews were conducted with individuals who 1) have experience conducting arthritis research studies; 2) reside in and/or conduct their research in Canada; and 3) speak English or French.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!